Srinivasa P. S. Rao
Novartis (Switzerland)(CH)Research Institute for Tropical Medicine(PH)Novant Health(US)Novartis (United States)(US)Health Biomed (China)(CN)Novartis (Ireland)(IE)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Trypanosoma species research and implications, Research on Leishmaniasis Studies, Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms
Most-Cited Works
- → Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis(2013)600 cited
- → The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis(2008)528 cited
- → Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness(2016)408 cited
- → A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy(2010)304 cited
- → 3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin.(1994)247 cited
- → Characterization of the Taxol Binding Site on the Microtubule(1995)240 cited